

Ep. 238 - Biosecure Act: The Impact & What's Ahead
Jun 20, 2024
BioCentury editors discuss the impact of the Biosecure Act on Chinese CDMOs in the US. The delay in legislation raises questions about its future. Biotech sector debates the implications and strategies for navigating restrictions amid US-China tensions.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 2min
The Biosecure Act and National Defense Authorization Act
01:31 • 8min
Exploring the Intersection of Industry and Academia in R&D
09:06 • 2min
Impact of the Biosecure Act on the Biotech Industry
11:08 • 7min
Exploring the Early Stages of the Biotech Chips Act and Potential Geopolitical Impact
18:31 • 3min